Evicenter
MarkdownMedical informationP&T meetings
Lysergide (DT120)

Generalized anxiety disorder

Also known as MM120
Launch
Not announced
Last updated
199 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Selective serotonin reuptake inhibitors

19 evidence topics · 11 sources

Adverse reactions with escitalopram in adult GAD trials: incidence table
Adverse reactionLexapro (N=429)Placebo (N=427)
Headache“24%”“17%”
Nausea“18%”“8%”
Ejaculation disorder“14%”“2%”
Somnolence“13%”“7%”
Insomnia“12%”“6%”
Dry mouth“9%”“5%”
Fatigue“8%”“2%”
Libido decreased“7%”“2%”
Anorgasmia“6%”“<1%”
Relapse after discontinuation: meta-analysis of relapse prevention trials, SSRI subgroup